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uring heart development endocardial cells within
the atrio-ventricular (AV) region undergo TGF
 
 
 
-
dependent epithelial-mesenchymal transformation
(EMT) and invade the underlying cardiac jelly. This process
gives rise to the endocardial cushions from which AV
valves and part of the septum originate. In this paper we
show that in mouse embryos and in AV explants TGF
 
 
 
induction of endocardial EMT is strongly inhibited in mice
deﬁcient for endothelial 
 
 
 
-catenin, leading to a lack of
heart cushion formation. Using a Wnt-signaling reporter
mouse strain, we demonstrated in vivo and ex vivo that
D
 
EMT in heart cushion is accompanied by activation of
 
 
 
-catenin/TCF/Lef transcriptional activity. In cultured endo-
thelial cells, TGF
 
 
 
2 induces 
 
 
 
-smooth muscle actin (
 
 
 
SMA)
expression. This process was strongly reduced in 
 
 
 
-catenin
null cells, although TGF
 
 
 
2 induced smad phosphorylation
was unchanged. These data demonstrate an involvement of
 
 
 
-catenin/TCF/Lef transcriptional activity in heart cushion
formation, and suggest an interaction between TGF
 
  
 
and
Wnt-signaling pathways in the induction of endothelial-
mesenchymal transformation.
 
Introduction
 
The heart is the first organ to be formed in the developing
vertebrate embryo and originates from the splachnic lateral
mesoderm. A specific subpopulation of cells, the cardiogenic
mesoderm, gives rise to the first two types of heart cells,
which are the myocardial and endocardial cells. The latter
acquire endothelial markers, like VE-cadherin, Tie-1, Tie-2,
VEGFRI/II, and PECAM/CD31. Furthermore, it is known
that endothelial/endocardial cells in the atrio-ventricular
(AV) canal give rise to the mesenchymal heart cushion cells,
which form the mesenchymal portion of cardiac septa and
valves (Markwald et al., 1977; Potts et al., 1991). To accom-
plish this, endocardial cells undergo an epithelial-mesenchymal
transformation (EMT), a process, which has been shown in
mammals to be largely dependent on TGF
 
 
 
 signaling
(Camenisch et al., 2002). The classical TGF
 
 
 
-signaling path-
way is characterized by a heteromeric receptor complex, con-
sisting of two type II and two type I receptors (Derynck and
Feng, 1997; Massague, 2000). In endothelial cells two type I
receptors, Alk-1 and Alk-5, which interact with the common
type II receptor, confer specificity of TGF
 
 
 
 signaling
(Goumans et al., 2002). Upon TGF
 
 
 
-binding, the receptor
complex undergoes a series of phosphorylations, activat-
ing the serin-threonine kinase function of the type I recep-
tor. This, in turn, phosphorylates proteins of the receptor
smad (R-smad) family, which translocate to the nucleus and,
together with accessory transcription factors, initiate tar-
get-gene transcription (Itoh et al., 2000; Massague, 2000;
Moustakas et al., 2001). Recently, evidence has been pre-
sented that smads can also interact with 
 
 
 
-catenin and TCF/
Lef transcription factors, which are downstream effectors of
the Wnt-signaling pathway (Labbe et al., 2000; Nishita et
al., 2000; Tian and Phillips, 2002).
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Many members of the Wnt family of growth and differen-
tiation factors act by stabilizing 
 
 
 
-catenin in the cytosol and
promoting its accumulation in the nucleus, where it binds
and activates TCF/Lef transcription factors (Gumbiner,
1995; Behrens et al., 1996; Miller and Moon, 1996; Zhu-
rinsky et al., 2000; Hurlstone and Clevers, 2002). In the
vascular system, the role of Wnt signaling and of 
 
 
 
-catenin
transcriptional activity has not been fully elucidated yet. To
investigate this aspect we specifically inactivated the 
 
 
 
-cate-
nin gene in endothelial cells, using the Cre-loxP system.
This resulted in embryonic lethality around mid-gestation
due to vascular fragility and defects in placentation (Cat-
telino et al., 2003).
Here, we show that also heart development is severely af-
fected in mutant mice and that endothelial deficiency of
 
 
 
-catenin leads to a lack of heart cushion formation by 10.5 d
post coitum (dpc). In vivo and ex vivo we found that
TGF
 
 
 
2 induction of EMT of endocardial cells is accompa-
nied by activation of 
 
 
 
-catenin transcriptional activity and is
strongly inhibited in mice deficient for endothelial 
 
 
 
-cate-
nin. In addition, the impairment of 
 
 
 
-catenin null cells to
transform into 
 
 
 
SMA-positive cells upon TGF
 
 
 
2 stimula-
tion has been demonstrated also in vitro. The data presented
here suggest a cross-talk between TGF
 
 
 
 and Wnt-signaling
pathways during EMT in heart cushion formation.
 
Results
 
 
 
-Catenin deficiency in endothelial cells leads to 
defective septum formation in the heart
 
To specifically inactivate the 
 
 
 
-catenin gene in endothelial
cells, we crossed transgenic mice carrying a 
 
 
 
-catenin allele
flanked by two loxP sites (Brault et al., 2001), with mice ex-
pressing the Cre recombinase under the endothelial-specific
Tie2 promoter (Schlaeger et al., 1997; Kisanuki et al.,
2001). These animals die between 11.5 and 13.0 dpc due to
an altered development of the vascular system (Cattelino et
al., 2003).
In this paper, we focused on the alterations in heart devel-
opment due to 
 
 
 
-catenin deficiency in the endocardium.
The lack of endocardial 
 
 
 
-catenin was confirmed previously
by immunofluorescence (Cattelino et al., 2003). Embryos at
9.5–10.5 dpc were fixed, stained in whole mount for the en-
dothelial marker PECAM/CD31, embedded in paraffin,
sectioned and counterstained with nuclear fast red. At 9.5
dpc, before endocardial-mesenchymal transformation ini-
tiates, knockout (KO) and wild-type (WT) littermates were
indistinguishable concerning the development of the heart
(unpublished data). From 9.5 to 10.5 dpc, in all embryos
analyzed (30WT; 15 KO), we observed a divergent forma-
tion of the heart cushion. At 10.5 dpc, the cardiac cushion
of KO embryos showed a dramatically decreased cellularity
as compared with WT littermates (Fig. 1, compare A and C
with B and D), which was confirmed quantifying the cell
numbers in heart cushions (Fig. 1 E). This indicates a re-
duced or largely missing ability of KO endocardial cells to
undergo EMT and to invade the cardiac jelly. Although the
endocardium was stained positive for PECAM/CD31, it is
noteworthy that the cells inside the heart cushion at 10.5
dpc were negative for this endothelial marker. This confirms
previous reports that endocardial cells lose their endothelial
markers during EMT (Nakajima et al., 1997; Camenisch et
al., 2002; Frid et al., 2002).
 
Endocardial cells from 
 
 
 
-catenin mutant embryos fail 
to transform in an ex vivo AV explant assay
 
To directly characterize the defect of endocardial cells to in-
vade the cardiac jelly and to exclude prelethal, secondary ef-
fects at 10.5 dpc, we dissected the AV regions of WT and
KO embryos at E9.5 dpc and subjected them to an ex vivo
assay for EMT in the AV heart cushion (Runyan and Mark-
wald, 1983; Potts et al., 1991). This assay mimics endocar-
dial EMT in vitro, as the TGF
 
 
 
2 and other stimuli for the
endocardial cells to undergo transformation are provided by
the myocardium, which is included. The explants were
placed on top of a collagen I gel with the endocardial layer
upside down and incubated under standard cell culture con-
ditions for up to 48 h. In total, 64 AV explants were gener-
ated of which 46 were 
 
 
 
-catenin positive (either homo- or
heterozygous) and 18 were deficient for endocardial 
 
 
 
-cate-
nin. About 70% of both types of explants, with and without
endocardial 
 
 
 
-catenin, attached firmly to the collagen gel
and spontaneously started contracting in vitro. Only these
explants were considered for consecutive investigations. We
Figure 1. Heart cushion defect in endothelial  -catenin null 
embryos. (A–D) Paraffin sections of mouse embryos at 10.5 dpc 
stained in whole mount for PECAM/CD31 (blue) and counterstained 
with nuclear fast red. (A and C) Sections of a control embryo showing 
the heart region in low and high magnification, respectively. Note 
the heart cushion (asterisk) filled with mesenchymal cells. Arrow-
heads in C point to the endocardium. (B and D) Sections of a repre-
sentative KO embryo in the same plane of the control. The heart 
cushion (asterisk) is almost completely devoid of mesenchymal 
cells. (E) Number of cells in the heart cushion of control and KO 
embryos, as counted in six serial 6- m sections of three embryos, 
respectively. Columns represent means   SD; P   0.0001 by t test. 
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did not observe any differences between WT and KO ex-
plants in attachment and survival. Neither could we observe
a difference in the number of apoptotic cells in explants with
or without endothelial 
 
 
 
-catenin (Fig. S1, available at http:
//www.jcb.org/cgi/content/full/jcb.200403050/DC1).
In phase contrast, endothelial cells of WT AV explants
were widely spread on the gel, showing a largely scattered,
mesenchymal morphology (Fig. 2 A). Instead, endothelial
cells of KO AV explants grew out predominantly in a mono-
layer, bearing cobblestone morphology (Fig. 2 D). As the in-
vasion of the collagen gel is considered the hallmark for oc-
currence of EMT (Potts et al., 1991), we characterized the
distribution of the outgrowing endothelial cells both on the
surface and inside the collagen lattice. The explants were
fixed and stained for F-actin together with a nuclear coun-
terstaining (DAPI) and subjected to confocal microscopy
(Fig. 2, B, C, E, and F). In contrast to the long, spindle-like
endothelial cells observed in WT explants, those lacking
 
 
 
-catenin maintained epithelioid characteristics, which was
visualized by F-actin staining (Fig. 2, B and E, respectively).
Performing a confocal scanning of the explants in z axis,
we could demonstrate that cells from the WT AV explants
invaded the gel (Fig. 2 C), whereas in KO explants cells
largely failed to invade the collagen gel and remained on the
gel surface (Fig. 2 F). The cells, which have undergone EMT
have been quantified and their number per gel volume has
been plotted (Fig. 2 G). These data confirm the observation
in vivo in heart cushion formation.
 
TCF/Lef/
 
 
 
-catenin signaling occurs during endothelial-
mesenchymal transformation in the developing heart 
and in AV explants
 
To directly investigate whether 
 
 
 
-catenin transcriptional ac-
tivity is involved in endocardial EMT, we made use of a
transgenic mouse line containing a 
 
 
 
-catenin/TCF/Lef–
specific reporter construct (BAT-gal), which, upon activa-
tion, results in a nuclear accumulation of 
 
 
 
-galactosidase
(Maretto et al., 2003).
At 10.5 dpc, single cells in the heart cushion stained posi-
tive for nuclear 
 
 
 
-galactosidase, indicating activation of
 
 
 
-catenin /TCF/Lef transcriptional activity (Fig. 3, A and B).
In ex vivo EMT assays described above, AV explants from
BAT-gal mice behaved like WTs concerning their ability to
grow out and to invade the gel. Interestingly, single cells in
the outgrowing endothelial cell layer regularly stained posi-
tive for nuclear 
 
 
 
-galactosidase, confirming the in vivo data
(Fig. 3, C and D). Some, but not all, of these cells could be
labeled for both PECAM/CD31 and 
 
 
 
-galactosidase indicat-
ing their endothelial origin (Fig. 3 D). The fact that several
invading cells could not be labeled with PECAM can be ex-
plained by the loss of endothelial markers during EMT (Fig.
1 C; Frid et al., 2002). Therefore, to unequivocally demon-
strate the endothelial origin of the invading cells in the ex
vivo AV explant assay, we crossed mice transgenic for the
 
Figure 2.
 
Endocardial cells from 
 
 
 
-catenin mutant embryos fail to 
transform in an ex vivo AV explant assay.
 
 (A and D) Phase-contrast 
micrographs of the AV explant on top of the collagen I gel after 48 h 
in culture, from control and endothelial 
 
 
 
-catenin KO embryos (9.5 
dpc), respectively. Note the scattered and widespread appearance 
of the outgrowing endothelial cells in the control (A), compared 
with the KO, where endothelial cells grew out in a monolayer on 
top of the gel, showing an compact, epithelial-like morphology (D). 
(B and E) AV explants from control and KO embryos, respectively, 
have been labeled for F-actin (green) and nuclei with DAPI (blue). 
Confocal stack of images presented as a maximal projection in the 
z axes. (C and F, left) Nuclear fluorescent staining with DAPI pre-
sented as an overlay of confocal xy-images, showing all cell nuclei 
in a maximal projection in the z axes, of control and KO explants, 
respectively. (C and F, right) Three different z-scans. The corre-
sponding horizontal section level in the xy-image on the left, and 
individual cells of interest are indicated by the colored arrowheads. 
Dashed lines indicate the border of the AV explants in the xy-images 
on the left panels and the surface of the collagen gel in the z-images 
on the right panels, respectively. Note that KO cells remain mainly 
organized in a monolayer on top of the gel (F, arrowheads), whereas 
some WT cells are regularly found in the gel (C, arrowheads). (G) 
quantification of cells inside the collagen gel. Confocal sections in 
focal planes below the gel surface were counted for the presence 
of cells, indicated by nuclear staining for DAPI. (AV explants, 
 
n 
 
  
 
7 
for WT and KO, respectively). Columns represent means 
 
 
 
 SD; 
P 
 
  
 
0.0001 by 
 
t 
 
test. 
362 The Journal of Cell Biology 
 
|
 
 
 
Volume 166, Number 3, 2004
 
Tie2-Cre construct (Schlaeger et al., 1997; Kisanuki et al.,
2001) with ROSA26 reporter mice. The double-transgenic
offspring bears an irreversible expression of the lacZ gene in
endothelial cells after Cre-mediated recombination (Soriano,
1999). As reported in Fig. 3 (E–G), essentially all the cells
outgrowing from the explant and invading the gel were posi-
tive for 
 
 
 
-galactosidase indicating their endothelial origin.
 
 
 
-Catenin–deficient endothelial cells show impaired 
TGF
 
 
 
2-induced transformation in vitro
 
To understand the mechanism of action of 
 
 
 
-catenin in pro-
moting TGF
 
 
 
-induced endothelial EMT we have set up an
in vitro system. As reported previously, we isolated, cul-
tured, and characterized endothelial cells from KO animals
(Cattelino et al., 2003). The 
 
 
 
-catenin–deficient cells were
infected with an empty retroviral vector (KO
 
vc
 
), or with
the same vector containing the full-length 
 
 
 
-catenin gene
(KO
 
fl-
 
 
 
cat
 
). The ability of the exogenous 
 
 
 
-catenin protein to
localize correctly at the membrane and to accumulate in the
nucleus, was confirmed by immunofluorescence staining
(Fig. S2, available at http://www.jcb.org/cgi/content/full/
jcb.200403050/DC1). It has been reported that under long-
term stimulation by TGF
 
 
 
, cultured endothelial cells could
transform into mesenchymal cells expressing 
 
 
 
SMA in a
similar way to what has been described for endocardial EMT
(Paranya et al., 2001; Frid et al., 2002). Because TGF
 
 
 
2
seems to be the most relevant TGF
 
 
 
-family member for
EMT in heart cushion formation (Camenisch et al., 2002),
the majority of the experiments were performed using
TGF
 
 
 
2. It is noteworthy that TGF
 
 
 
1 was also used with
comparable results (Fig. S3, available at http://www.jcb.org/
cgi/content/full/jcb.200403050/DC1).
Cells were seeded in sparse conditions and cultured in low
serum with and without addition of TGF
 
 
 
2 (1 ng/ml) for
5–7 d. Under these conditions, 44 
 
 
 
 5.7% of KO
 
fl-
 
 
 
cat
 
 cells
transformed into cells expressing 
 
 
 
SMA, whereas only 20 
 
 
 
1.4% of the 
 
 
 
-catenin–deficient cells were positive for 
 
 
 
SMA
(Fig. 4, A, B, and D). The significance of the difference was
calculated by a 
 
t 
 
test analysis and gave a P 
 
  
 
0.0001, whereas
in the absence of TGF
 
 
 
2 the number of 
 
 SMA-expressing
endothelial cells was equally low for both cell lines (Fig. 4 D).
Furthermore, we were able to double stain the majority
( 80%) of  SMA-positive cells with the endothelial marker
VE-cadherin confirming the endothelial origin of transform-
ing cells (Fig. 4 C). The growth rate of the two cell lines un-
Figure 3.  -Catenin/TCF/Lef transcriptional activity occurs during 
EMT in the heart cushion in vivo and ex vivo. (A) Paraffin section of 
a representative BAT-gal embryo (10.5 dpc) stained in whole mount 
for  -galactosidase and counterstained with Eosin, showing the 
region of the heart with the heart cushion (asterisk). Single cells in 
the heart cushion show a nuclear staining in blue. (B) Higher magni-
fication of A, endocardium is indicated by arrowheads. A, Atrium; 
V, ventricle. (C) Typical AV explant from BAT-gal embryo (9.5 dpc) 
after 48 h in culture showing single outgrowing cells stained positive 
for nuclear  -galactosidase (arrowheads). (D) Confocal image of 
a double staining for  -galactosidase (red) and PECAM (green) 
confirming the endothelial nature of the cells showing reporter 
activation (arrowhead). (E) Phase-contrast image of a representative 
AV explant derived from an embryo positive for the inherited 
expression of  -galactosidase (blue, staining) in endothelial cells. 
Note the mesenchymal-like outgrowth of the cells on and into the 
collagen gel. (F) Bright field image of the same explant described in 
E, showing clearly that virtually all cells grown out from the explant 
are of endothelial origin, as indicated by the blue staining for 
 -galactosidase. Note that also the original endocardial lining of 
the AV explant, which is still present underneath the myocardium, 
is positive for  -galactosidase. (G) Higher magnification of F.
Figure 4.  -Catenin is required for TGF 2-induced endothelial 
cells transformation into  SMA-positive cells in vitro. Endothelial 
 -catenin null cells infected with the full-length  -catenin gene 
(KO
fl- cat) (B and C) or with the empty vector (KO
vc) (A), were treated 
for 6 d with TGF 2, and fixed and stained for  SMA (green). (C) 
KO
fl- cat cells, which have receive the same treatment as in A and B, 
were double stained for VE-cadherin (red) and  SMA (green). The 
nuclear dye Hoechst (blue) was used to counterstain cells. (D) The 
number of  SMA-positive cells was expressed as a percentage of 
total cells (1–2   10
3 cells were counted for each cell line, and 
columns represents the mean out of four individual experiments   
SD; P   0. 0001 by t test). (E) BrdU incorporation in KO
vc and 
KO
fl- cat cell after TGF 2 stimulation. Cells were treated as described 
above and proliferation was measured for the two cell lines indi-
cated, as described in Materials and methods. The number of cells, 
which have incorporated BrdU in the nuclei, is presented as the 
mean percentage of total cells   SD. -Catenin and TGF  signaling in endothelial cells | Liebner et al. 363
der TGF 2 stimulation did not differ significantly, as deter-
mined by BrdU incorporation (Fig. 4 E).
TGF 2 signaling is not altered in endothelial cells 
deficient for  -catenin
We tested whether the absence of  -catenin could influence
TGF 2 signaling and in particular the activation of R-smads.
In endothelial cells two different TGF  type I receptors,
namely Alk-1 and Alk-5, signal through different R-smads,
smad1/5 and smad2/3, respectively (Goumans et al., 2002).
Therefore, phosphorylation and nuclear accumulation of
smad1/5 and smad2 as indicators of specific receptor activa-
tion were evaluated in KO
fl- cat and KO
vc cell lines. We found
that phospho-smad1/5 (P-smad1/5) and phospho-smad2
(P-smad2) were highly increased upon TGF 2 stimulation
in both cell lines (Fig. 5 A). In particular, the amount of
P-smad1/5 in the nuclear fraction of KO
fl- cat and KO
vc cells did
not differ in resting conditions, and was only slightly lower in
the KO
vc as compared with the KO
fl- cat after stimulation
with TGF 2 (Fig. 5 A). On the other hand, in KO
vc cells,
nuclear P-smad2 was not decreased in the absence of  -cate-
nin, both in resting conditions and after TGF 2 stimulation
(Fig. 5 A). Also the total amount of smads, evaluated by anti-
bodies against the nonphosphorylated forms of the proteins,
did not differ significantly between KO
fl- cat and KO
vc, with
and without TGF 2 stimulation (Fig. 5 B). These data sug-
gest that the overall ability of endothelial cells to respond to
TGF  in terms of activation of R-smads is not significantly
altered in the absence of  -catenin.
Notch1, delta-like 4, snail1, and VE-cadherin 
expression is not altered in endothelial cells deficient 
for  -catenin
It has been reported that Notch activity is required for en-
docardial EMT. In particular, Notch1 was found to be in-
creased in zebrafish when  -catenin transcriptional activity
was increased (Hurlstone et al., 2003). Therefore, we inves-
tigated whether inhibition of endothelial EMT in  -cate-
nin–deficient cells could be an indirect effect, due to an al-
teration of Notch1 expression. As reported in Fig. 6 A,
Notch1 was not modified in heart extracts of WT and KO
embryos at 10.5 dpc. In cultured endothelial cells with
or without  -catenin, Notch1 was not significantly modi-
fied under unstimulated conditions and slightly reduced
( 30%) in both cell lines after activation with TGF 2 (Fig.
6 B). The transcriptional expression level for the Notch
ligand delta-like 4 has been determined by quantitative real
time PCR and showed no significant differences between
cells with or without  -catenin, neither under basal, nor un-
der TGF 2-stimulated conditions (Fig. 6 D).
The transcription factor snail1 has been reported to play a
key role in epithelial and endothelial EMT (Batlle et al.,
Figure 5. The absence of  -catenin does not modify smads and 
their phosphorylation. (A) Western blots for phospho-smad1 and 5 
(P-smad1/5, arrowheads) and phospho-smad2 (P-smad2, arrowhead) 
from nuclear lysates prepared from KO
fl- cat and KO
vc cell lines. 
Cells were treated with or without TGF 2 (5 ng/ml) for 2 h before 
extraction. Both nuclear P-smad1/5 and 2 were increased after 
TGF 2 stimulation, with no significant change between KO
vc and 
KO
fl- cat cell lines. (B) Western blots of total lysates of smads1/5 
and smads2/3. Note that the total amounts of smads were not altered. 
 -Tubulin was used as a control for protein loads.
Figure 6. The absence of  -catenin does not modify VE-cadherin, 
Notch1, delta-like 4, and snail1 expression. (A) Total protein extracts 
from WT and KO hearts at 10.5 dpc were separated on 7% SDS-
PAGE. Immunoblotting for VE-cadherin and Notch1 revealed no 
significant differences in expression between WT and KO hearts. 
 -Tubulin was used as a control for protein loads. (B) KO
fl- cat and 
KO
vc endothelial cells, with or without stimulation of TGF 2, were 
analyzed by Western blotting for their expression of VE-cadherin 
and Notch1. In unstimulated conditions, KO
fl- cat and KO
vc cells 
show equal levels of expression for both proteins. After stimulation 
with TGF 2, both cell lines show  20% reduction in expression for 
both proteins.  -Tubulin was used as a control for protein loads. 
(C and D) Total RNA from KO
fl- cat and KO
vc endothelial cells, with 
or without stimulation with TGF 2, was retro-transcribed into cDNA 
and the relative level of gene expression (RQ) was analyzed by 
quantitative real time PCR for snail1 (C) and delta-like 4 (D). In both 
cell lines snail1 shows no different expression in basal conditions 
and was comparably up-regulated after TGF 2 stimulation. Delta-
like 4 did not show any significant regulation between the two cell 
lines, neither with nor without TGF 2. Error bars (RQmin/RQmax) 
are based on confidential level of 95%.364 The Journal of Cell Biology | Volume 166, Number 3, 2004
2000; Cano et al., 2000; Savagner, 2001; Timmerman et al.,
2004). In cultured endothelial cells snail1 expression was in-
creased by TGF 2 as reported previously (Valdes et al.,
2002) but this effect was comparable in the presence or ab-
sence of  -catenin (Fig. 6 C).
Finally, because cadherins are targets of snail and are
known to be down-regulated during EMT, we studied VE-
cadherin expression in the embryonic heart and in cells in
vitro. We found that in total extract taken from hearts under-
going AV endocardial EMT, VE-cadherin protein levels were
not significantly different between WT and KO samples (Fig.
6 A). The same was true for endothelial cells in culture, with
or without  -catenin (Fig. 6 B). It is noteworthy that under
stimulation with TGF 2, VE-cadherin protein levels were
slightly down-regulated ( 20%) in both cell lines.
Together, these data indicate that the absence of  -cate-
nin does not alter the level of Notch1 receptor and delta-like
4 ligand. Moreover, it does not alter the ability of TGF 2 to
influence the level of snail1 and of VE-cadherin, suggesting
that  -catenin is not upstream of snail1.
Discussion
In embryonic development, EMT occurs when epithelial
cells become migratory, invade new microenvironments and
acquire mesenchymal characteristics such as elongated mor-
phology, rearranged actin cytoskeleton, increased produc-
tion of lytic enzymes, loss of apical/basal polarity, and junc-
tion organization (Thiery, 2002).
During heart development a subset of endocardial cells,
located in the AV and cono-ventricular regions, detaches
from the endocardial sheet and invades the underlying car-
diac jelly to form the endocardial cushions, which give rise
to valves and septa. This appears to be a typical EMT of a
subset of endocardial cells. TGF  plays an important role in
this phenomenon but the molecular mechanisms controlling
the process have only been partially clarified.
In this paper, we provide evidence that induction of EMT
in the endocardial cells requires  -catenin transcriptional ac-
tivity. The requirement for  -catenin was demonstrated by
the observation that in mice, in which the  -catenin gene
was selectively inactivated in endothelial/endocardial cells,
the heart cushion fails to develop. In these embryos, en-
docardial cells do not undergo EMT. This was demon-
strated in vivo by a strong reduction of cellularity in the car-
diac jelly and ex vivo in AV explants by the failure of
endocardial cells to acquire mesenchymal characteristics and
to invade the collagen gel. In addition, cultured endothelial
cells deficient for  -catenin exhibit an impaired ability to
undergo transformation and to express  SMA upon stimu-
lation with TGF 2.
These defects are most likely due to a lack of  -catenin
transcriptional activity because in reporter mice, cells invad-
ing the cardiac jelly or growing out into the collagen gel in
AV explants, express the reporter gene LacZ.
These results are in agreement with a recent publication
by Hurlstone et al. (2003) in zebrafish, showing that a lack
of function mutation in the adenomatous polyposis coli gene,
leads to increased  -catenin signaling and results in excessive
and misplaced endocardial cushion formation. Conversely,
overexpression of adenomatous polyposis coli or inhibition of
Wnt by Dickkopf 1 inhibited this phenomenon. These find-
ings support the idea of a prominent role of the Wnt/ -cate-
nin pathway in determining endocardial cell fate.
Interestingly, in vivo and in the AV explants only a lim-
ited number of cells were  -galactosidase positive suggesting
that activation of  -catenin transcriptional activity is a tran-
sient phenomenon, which likely follows a specific temporal
pattern. We demonstrated that single cells expressed both
endothelial markers and  -galactosidase in explants from
BAT-gal reporter mice. This suggests that  -catenin and/or
its transcriptional activity likely acts at early/intermediate
steps of cell transformation when cells have not yet acquired
full mesenchymal characteristics, while losing endothelial
characteristics.
Using explants from ROSA26 mice crossed with Tie2-Cre
transgenics, in which Tie2-Cre induces LacZ expression in
endothelial cells in an irreversible way, we demonstrated that
virtually all cells in AV explants, undergoing EMT are of en-
dothelial origin. These data fully support previous work in
vivo on mouse heart development (Kisanuki et al., 2001).
In cultured cells, TGF 2 induced  SMA expression in
the endothelium in a  -catenin–dependent way.  SMA is
the most frequently used marker of EMT in the endocar-
dium (Paranya et al., 2001) and, with the limitations of a
culture system, these results support the data in vivo and in
organ culture. In addition, the observations on cultured cells
suggest that the effect of TGF 2 is cell-autonomous, not re-
quiring the interaction with other contiguous cells types
present in vivo. Our data support a model in which both
 -catenin/TCF/Lef transcriptional activity and TGF  signal-
ing are required for EMT, but whether these two pathways
directly interact, or whether one or the other is upstream, re-
mains to be elucidated. Interestingly, from the data reported
here, TGF  signaling through smads is not significantly al-
tered by the absence of  -catenin, arguing in favor of a role
of  -catenin in parallel or downstream of smads. It has been
reported that members of the Wnt-signaling pathway like
 -catenin and TCF/Lef can independently interact with
smad2, smad3, and smad4 (Labbe et al., 2000; Nishita et al.,
2000; Tian and Phillips, 2002). Nishita et al. (2000) and
Labbe et al. (2000) also show that during development of
Xenopus laevis a number of target genes exhibit responsive-
ness to both Wnt and TGF  signals.
A recent paper demonstrates that TGF 3 can up-regulate
Lef-1 transcription during EMT in mouse palatal develop-
ment (Nawshad and Hay, 2003). When smad2 and smad4
are present in the nucleus, Lef-1 is activated without  -cate-
nin. Smad2/4 would therefore interact preferentially with
Lef-1 if  -catenin is absent. However, Nawshad and Hay
(2003) found that palatal EMT would be promoted in the
absence of  -catenin, likely by a Lef–smad2 complex, which
is neither the case in the present work in mouse, nor in a ze-
brafish model (Hurlstone et al., 2003). Therefore, it is con-
ceivable that the mechanism through which TGF  induces
EMT in endocardial cells is not identical to those in the pal-
atal epithelium. Most likely, this might depend on the endo-
thelial-specific expression of TGF  and/or Wnt receptors.
Other signaling pathways, like EGF, VEGF, and BMP,
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(Brown et al., 1999; Dor et al., 2001; Kim et al., 2001; Iwa-
moto et al., 2003). It was recently reported that also Notch
activity promotes EMT during cardiac development via tran-
scriptional induction of the snail1 repressor, which facilitates
VE-cadherin down-regulation (Noseda et al., 2004; Timmer-
man et al., 2004). The authors, using endothelial cells in-
duced to transform by activated Notch, could not find evi-
dence for TGF  activation. This suggests that Notch may act
independently from TGF . To understand if in endothelial
cells genes of the Notch signaling pathway are altered in the
absence of  -catenin, we analyzed the expression of Notch1,
delta-like 4, but we could not find any significant regulation
neither in vivo, nor in vitro (Fig. 6). Interestingly, upon stim-
ulation with TGF 2, snail1 is equally up-regulated in cells
with and without  -catenin, suggesting on the one hand that
 -catenin is not upstream of snail1, on the other hand that
snail1 expression is not sufficient to promote control levels of
EMT in the absence of  -catenin. As a late target of EMT,
protein expression levels of VE-cadherin were analyzed, but
we could not find any significant regulation neither in vivo,
nor in vitro, between WT and KO (Fig. 6). However, upon
TGF 2 stimulation of cells in vitro, only a slight decrease of
protein levels for VE-cadherin could be detected in both cell
lines (Fig. 6 B). This observation is supported by immuno-
staining, in which the majority of cells positive for  SMA
also express VE-cadherin (Fig. 4 C). Overall these data sug-
gest that  -catenin may act to a large extent at early stages of
EMT, before VE-cadherin down-regulation.
However, keeping in mind that cadherins may indirectly
regulate the free pool of  -catenin (Gumbiner, 1995; Nel-
son and Nusse, 2004), we cannot exclude that the slight
down-regulation of VE-cadherin observed upon TGF 2
might contribute to  -catenin signaling level, thus providing
a possible link between Wnt and TGF  signaling.
In conclusion, endocardial EMT leading to cell invasion of
the cardiac jelly is a complex phenomenon, in which different
signaling pathways may interplay. There is growing evidence
from different in vivo and in vitro systems that vascular endo-
thelial cells may acquire smooth muscle cell markers and can
contribute to vessel wall formation during development as
well as during pathological conditions, such as artherosclerosis
and restenosis (DeRuiter et al., 1997; Frid et al., 2002; Iurlaro
et al., 2003; Yurugi-Kobayashi et al., 2003). Therefore, the
comprehension of the mechanisms underlying endothelial/en-
docardial transformation will be crucial not only for the un-
derstanding of diseases like congenital heart defects, but also
of artherosclerotic degenerations of the vessel wall.
Materials and methods
Transgenic mice and crossings
The generation of  -catenin flox and flox del mice has been described pre-
viously (Brault et al., 2001). The Tie2-Cre transgenic mice were a gift of M.
Yanagisawa (Schlaeger et al., 1997; Kisanuki et al., 2001). The mating
scheme and the genotyping of the animals have been described previously
(Cattelino et al., 2003).
Transgenic Wnt-signaling reporter animals have been described previ-
ously (Maretto et al., 2003). In brief, BAT-gal was constructed by fusing seven
TCF/Lef-binding sites upstream of a 0.13-kb fragment containing the minimal
promoter-TATA box of the gene siamois upstream of the  -galactosidase
gene (Brannon et al., 1997). Transgenics were crossed into a CD1 outbred
mouse background and used for embryo analysis and heart explants.
Antibodies
Mouse mAbs were as follows: anti- SMA (clone 1A4) was purchased from
Sigma-Aldrich and anti– -tubulin was purchased from Molecular Probes.
The rat anti-PECAM/CD31 clone MEC7.46 mAb has been described previ-
ously (Vecchi et al., 1994).
pAbs were as follows: anti–P-smad1/5 and anti–P-smad2, as well as
anti-smad1/5 and anti-smad2/3 were purchased from Upstate Biotechnol-
ogy; goat anti– -galactosidase was purchased from Biogenesis; goat anti–
VE-cadherin was purchased from Research Diagnostics Inc.; and goat anti-
Notch1 was purchased from Santa Cruz Biotechnology.
Embryological techniques and immunostaining
Whole mount staining with anti-PECAM antibodies has been described
previously (Cattelino et al., 2003). For histological examination, fixed em-
bryos were dehydrated, embedded in paraffin, and sectioned at 6  m ac-
cording to standard procedures. Sections were dewaxed, rehydrated, and
counter stained with Eosin or Nuclear Fast red (Vector Laboratories). Im-
munostaining on PFA fixed specimens was performed as described previ-
ously (Lampugnani et al., 2002; Cattelino et al., 2003). For  SMA, cultured
cells were fixed for 5 min at  20 C in methanol and primary ascite was di-
luted 1:1,000.
Immunostaining of heart explants and of endothelial cells, was per-
formed as described previously (Liebner et al., 2000; Cattelino et al.,
2003). For visualizing BrdU incorporation, cells were stained with mouse
monoclonal anti-BrdU antibodies (Amersham Biosciences), followed by
TRITC-conjugated antibody to mouse immunoglobulin (DakoCytomation).
Specimens were conterstained with the nuclear dye DAPI or with Hoechst
33258 (Sigma-Aldrich) and mounted in 90% glycerol containing paraphe-
nylenediamine as an antibleaching agent. Fluorescence was observed ei-
ther with an epifluorescence microscope (Leica) and digitally documented
with a camera (model SenSys; Roper Scientific) or confocal microscope
(model TCS2; Leica). Images were computer processed using Adobe Pho-
toshop 7 for Macintosh.
Heart explant assay
All AV tissue was harvested from timed matings at 9.5 dpc of develop-
ment. The AV canal region was dissected from embryos in sterile PBS and
placed on top of drained rat type I collagen (Collaborative Biomedical
Products) gel as described previously (Runyan and Markwald, 1983; Potts
et al., 1991). The AV explants were maintained in M199 medium supple-
mented with 1% FBS (Hyclone), 100 U/ml penicillin, 100 mg/ml strepto-
mycin, and 0.1% insulin, transferrin, and selenium (GIBCO BRL) in four-
well microculture dishes (Nalge-Nunc). AV explants were allowed to
firmly attach overnight ( 14 h) before addition of 100 ml of M199 explant
media. AV explants cultures were grown at 37 C with 5% CO2.
Explant cultures were fixed with 4% PFA, rinsed twice with PBS, and
stained with Oregon green phalloidin and DAPI (Molecular Probes) to ob-
serve cellular and nuclear morphology. Images were acquired according to
the procedure described in Embryological techniques and immunostaining.
Culture of endothelial cells and retroviral infection
Endothelial cells with homozygous null mutation of the  -catenin gene (KO)
were isolated from 9.5 dpc embryos (Carmeliet et al., 1999; Balconi et al.,
2000; Cattelino et al., 2003). Cells were routinely cultured in DME with
15% FCS (Hyclone), endothelial cell growth supplement (5  g/ml; home-
made from calf brain), and heparin (100  g/ml; Sigma-Aldrich) maintenance
medium (Balconi et al., 2000) on gelatin-coated tissue culture vessels.
For the restoration of  -catenin, KO cells were infected with murine
full-length   -catenin in pINCO-GFP retroviral vector (KO
fl- cat), or with
pINCO-GFP retroviral vector alone, as a control (KO
vc). Infected cells were
sorted by FACS
® for GFP expression.
In vitro transdifferentiation and proliferation assays
To induce differentiation of endothelial cells into  SMA expressing mesen-
chymal cells, 1–2   10
3 endothelial cells were seeded in a 35-mm-diam
Petri dish and cultured in DME medium with 2% FCS in the presence or ab-
sence of 1 ng/ml TFG 2 for 5–7 d with a daily medium change. For BrdU
incorporation into nuclear structures, 50  M BrdU (Roche) was added to
cells 5h before fixation. Cells were fixed and analyzed according to the pro-
cedure described in Embryological techniques and immunostaining.
Nuclear extraction and Western blot analysis
Cells (10
5/cm
2) were cultured for 4 d in maintenance medium, serum de-
prived for 48 h and, if desired, stimulated with TGF 2 for 2 h. Cells were
scraped in lysis buffer (20 mM Tris and 150 mM NaCl, pH 7.4, containing
0.5% Triton X-100, 10% glycerol, 1 mM PMSF, 2 mM Ca
2 , 15  g/ml leu-366 The Journal of Cell Biology | Volume 166, Number 3, 2004
peptin, 71  g/ml phenanthrolyne, and 20 U/ l aprotine [Sigma-Aldrich],
300  M vanadate, and 600 mM hydrogen peroxide). Extraction of DNA-
binding proteins was performed according to the method described by An-
drews and Faller (1991). The protein content was measured using the BCA
method (Pierce Chemical Co.). Total cell extracts were obtained by lysing
the cells in boiling 2  Laemmli buffer. Total and nuclear extracts were sep-
arated by 7 or 10% SDS-PAGE under reducing conditions and analyzed in
immunoblot with specific antibodies according to standard procedures.
Quantitative real time PCR
2  g of total RNA from different samples were reverse transcribed in a final
volume of 50  l using Taqman reverse transcriptions reagents. To avoid
amplification of contaminating genomic DNA, samples were previously
treated with RQ1 RNase-free DNase (Promega). Primers and probe se-
quences for mouse snail1and for the ribosomal 18S rRNA, which served as
a reference gene, were purchased from Applied Biosystems. The probes
Taqman predeveloped assay reagent was labeled with the reporter dye
VIC. All PCR reactions were performed using an ABI Prism 7700 sequence
detection system. For any sample, the expression levels for snail1 and
delta-like 4, normalized to the housekeeping gene 18S rRNA, were deter-
mined using the comparative threshold cycle method as described previ-
ously (Lu et al., 2001; Spagnuolo et al., 2004).
Online supplemental material
Antibody.  Anti– -catenin mAb was purchased from BD Biosciences.
Apoptosis assay.  AV heart explants were prepared as described in Heart
explant assays. After 48 h of incubation ex vivo, explants were fixed and
apoptosis was quantified by measuring DNA fragmentation (TUNEL detec-
tion method; Roche).
Nuclear localization of  -catenin.  Cells were serum starved for 24 h and
treated for 3 h with 6 mM LiCl and 5 ng/ml Leptomycin B (Sigma-Aldrich)
in the presence of 15% FCS. Cells were fixed and stained for  -catenin as
described in the Materials and methods.
Fig. S1 shows apoptosis in AV heart explants from WT and KO embryos.
AV heart explants from WT (A) and KO (B) embryos were stained by
TUNEL (red) and a nuclear counterstaining (DAPI, blue) and analyzed by
confocal microscopy. To quantify TUNEL-positive cells, stacks of images
(n   4 for WT and KO, respectively) were flattened on one layer, con-
verted into binary colors and automatically analyzed for stained particles
using ImageJ 1.32. Columns represent means   SD. Bar in B is valid for
both micrographs.
Fig. S2 shows nuclear localization of  -catenin in KO
vc and KO
fl- cat en-
dothelial cell lines. KO
vc (A) and KO
fl- cat (B) cell lines were treated with
LiCl and Leptomycin B, fixed, and immunostained for  -catenin. Under
these conditions, cells reinfected with full-length  -catenin show a pro-
nounced staining at the membrane (arrowheads) as well as an accumula-
tion of  -catenin in the nucleus (arrows), whereas KO
vc cells show no spe-
cific staining. Bar in A is valid for both micrographs.
Fig. S3 shows TGF 1-induced endothelial cells transformation into
 SMA-positive cells in vitro is impaired in the absence of  -catenin. The ex-
perimental setup was as described for Fig. 4, with the exception that KO
vc
and KO
fl- cat cell lines were treated with TGF 1 instead of TGF 2. The num-
ber of  SMA-positive cells was expressed as a percentage of total cells (1–2  
10
3 cells were counted for each cell line, and columns represents the mean
out of three individual experiments   SD. P   0.0001 by t test.
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